ESC 365 - Optimal antithrombotic therapy in cardiogenic shock - Conclusion and take home message.

ESC Premium Access

Optimal antithrombotic therapy in cardiogenic shock - Conclusion and take home message.

Session: Guidelines in Practice - How to treat high risk non-ST elevation myocardial infarction

Topic: Treatment

Speaker: Professor M. Roffi (Geneva, CH)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Professor Marco Roffi

University hospitals of Geneva, Geneva (Switzerland)

33 presentations

3 followers

8 more presentations in this session

Guidelines in Practice - How to treat high risk non-ST elevation myocardial infarction - Panel.

Case 1: Optimal antithrombotic therapy in cardiogenic shock.

Speaker: Doctor N. Ryan (Aberdeen, GB)

Optimal antithrombotic therapy in cardiogenic shock - What do the Guidelines say.

Speaker: Professor D. Mukherjee (El Paso, US)

Optimal antithrombotic therapy in cardiogenic shock - How to implement the guidelines.

Case 2: Haemodynamic support in unstable patients.

Speaker: Doctor F. van den Brink (Leiden, NL)

Access the full session

Guidelines in Practice - How to treat high risk non-ST elevation myocardial infarction

Speakers: Professor M. Roffi, Doctor N. Ryan, Professor D. Mukherjee, Doctor F. van den Brink

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources